Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL).
The global Idelalisib (CAL-101) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Idelalisib (CAL-101) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Idelalisib (CAL-101) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Idelalisib (CAL-101) include TCI, Biosynth Carbosynth, BOC Sciences, Focus Biomolecules, Adooq Bioscience, Selleck Chemicals, Enzo Biochem, Axon Medchem and BioVision, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Idelalisib (CAL-101), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idelalisib (CAL-101).
Report Scope
The Idelalisib (CAL-101) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Idelalisib (CAL-101) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Idelalisib (CAL-101) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TCI
Biosynth Carbosynth
BOC Sciences
Focus Biomolecules
Adooq Bioscience
Selleck Chemicals
Enzo Biochem
Axon Medchem
BioVision
Santa Cruz Biotechnology
Clearsynth
LGC
LKT Laboratories
Shimadzu
Aladdin
Cayman Chemical
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Idelalisib (CAL-101) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Idelalisib (CAL-101) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Idelalisib (CAL-101) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Idelalisib (CAL-101) Market Overview
1.1 Product Definition
1.2 Idelalisib (CAL-101) Segment by Type
1.2.1 Global Idelalisib (CAL-101) Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Idelalisib (CAL-101) Segment by Application
1.3.1 Global Idelalisib (CAL-101) Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Research
1.3.3 Medical
1.4 Global Market Growth Prospects
1.4.1 Global Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Idelalisib (CAL-101) Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Idelalisib (CAL-101) Production Estimates and Forecasts (2019-2030)
1.4.4 Global Idelalisib (CAL-101) Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Idelalisib (CAL-101) Production Market Share by Manufacturers (2019-2024)
2.2 Global Idelalisib (CAL-101) Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Idelalisib (CAL-101), Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Idelalisib (CAL-101) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Idelalisib (CAL-101) Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Idelalisib (CAL-101), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Idelalisib (CAL-101), Product Offered and Application
2.8 Global Key Manufacturers of Idelalisib (CAL-101), Date of Enter into This Industry
2.9 Idelalisib (CAL-101) Market Competitive Situation and Trends
2.9.1 Idelalisib (CAL-101) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Idelalisib (CAL-101) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Idelalisib (CAL-101) Production by Region
3.1 Global Idelalisib (CAL-101) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Idelalisib (CAL-101) Production Value by Region (2019-2030)
3.2.1 Global Idelalisib (CAL-101) Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Idelalisib (CAL-101) by Region (2025-2030)
3.3 Global Idelalisib (CAL-101) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Idelalisib (CAL-101) Production by Region (2019-2030)
3.4.1 Global Idelalisib (CAL-101) Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Idelalisib (CAL-101) by Region (2025-2030)
3.5 Global Idelalisib (CAL-101) Market Price Analysis by Region (2019-2024)
3.6 Global Idelalisib (CAL-101) Production and Value, Year-over-Year Growth
3.6.1 North America Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
3.6.5 India Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
4 Idelalisib (CAL-101) Consumption by Region
4.1 Global Idelalisib (CAL-101) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Idelalisib (CAL-101) Consumption by Region (2019-2030)
4.2.1 Global Idelalisib (CAL-101) Consumption by Region (2019-2024)
4.2.2 Global Idelalisib (CAL-101) Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Idelalisib (CAL-101) Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Idelalisib (CAL-101) Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Idelalisib (CAL-101) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Idelalisib (CAL-101) Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Idelalisib (CAL-101) Production by Type (2019-2030)
5.1.1 Global Idelalisib (CAL-101) Production by Type (2019-2024)
5.1.2 Global Idelalisib (CAL-101) Production by Type (2025-2030)
5.1.3 Global Idelalisib (CAL-101) Production Market Share by Type (2019-2030)
5.2 Global Idelalisib (CAL-101) Production Value by Type (2019-2030)
5.2.1 Global Idelalisib (CAL-101) Production Value by Type (2019-2024)
5.2.2 Global Idelalisib (CAL-101) Production Value by Type (2025-2030)
5.2.3 Global Idelalisib (CAL-101) Production Value Market Share by Type (2019-2030)
5.3 Global Idelalisib (CAL-101) Price by Type (2019-2030)
6 Segment by Application
6.1 Global Idelalisib (CAL-101) Production by Application (2019-2030)
6.1.1 Global Idelalisib (CAL-101) Production by Application (2019-2024)
6.1.2 Global Idelalisib (CAL-101) Production by Application (2025-2030)
6.1.3 Global Idelalisib (CAL-101) Production Market Share by Application (2019-2030)
6.2 Global Idelalisib (CAL-101) Production Value by Application (2019-2030)
6.2.1 Global Idelalisib (CAL-101) Production Value by Application (2019-2024)
6.2.2 Global Idelalisib (CAL-101) Production Value by Application (2025-2030)
6.2.3 Global Idelalisib (CAL-101) Production Value Market Share by Application (2019-2030)
6.3 Global Idelalisib (CAL-101) Price by Application (2019-2030)
7 Key Companies Profiled
7.1 TCI
7.1.1 TCI Idelalisib (CAL-101) Corporation Information
7.1.2 TCI Idelalisib (CAL-101) Product Portfolio
7.1.3 TCI Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.1.4 TCI Main Business and Markets Served
7.1.5 TCI Recent Developments/Updates
7.2 Biosynth Carbosynth
7.2.1 Biosynth Carbosynth Idelalisib (CAL-101) Corporation Information
7.2.2 Biosynth Carbosynth Idelalisib (CAL-101) Product Portfolio
7.2.3 Biosynth Carbosynth Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Biosynth Carbosynth Main Business and Markets Served
7.2.5 Biosynth Carbosynth Recent Developments/Updates
7.3 BOC Sciences
7.3.1 BOC Sciences Idelalisib (CAL-101) Corporation Information
7.3.2 BOC Sciences Idelalisib (CAL-101) Product Portfolio
7.3.3 BOC Sciences Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.3.4 BOC Sciences Main Business and Markets Served
7.3.5 BOC Sciences Recent Developments/Updates
7.4 Focus Biomolecules
7.4.1 Focus Biomolecules Idelalisib (CAL-101) Corporation Information
7.4.2 Focus Biomolecules Idelalisib (CAL-101) Product Portfolio
7.4.3 Focus Biomolecules Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Focus Biomolecules Main Business and Markets Served
7.4.5 Focus Biomolecules Recent Developments/Updates
7.5 Adooq Bioscience
7.5.1 Adooq Bioscience Idelalisib (CAL-101) Corporation Information
7.5.2 Adooq Bioscience Idelalisib (CAL-101) Product Portfolio
7.5.3 Adooq Bioscience Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Adooq Bioscience Main Business and Markets Served
7.5.5 Adooq Bioscience Recent Developments/Updates
7.6 Selleck Chemicals
7.6.1 Selleck Chemicals Idelalisib (CAL-101) Corporation Information
7.6.2 Selleck Chemicals Idelalisib (CAL-101) Product Portfolio
7.6.3 Selleck Chemicals Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Selleck Chemicals Main Business and Markets Served
7.6.5 Selleck Chemicals Recent Developments/Updates
7.7 Enzo Biochem
7.7.1 Enzo Biochem Idelalisib (CAL-101) Corporation Information
7.7.2 Enzo Biochem Idelalisib (CAL-101) Product Portfolio
7.7.3 Enzo Biochem Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Enzo Biochem Main Business and Markets Served
7.7.5 Enzo Biochem Recent Developments/Updates
7.8 Axon Medchem
7.8.1 Axon Medchem Idelalisib (CAL-101) Corporation Information
7.8.2 Axon Medchem Idelalisib (CAL-101) Product Portfolio
7.8.3 Axon Medchem Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Axon Medchem Main Business and Markets Served
7.7.5 Axon Medchem Recent Developments/Updates
7.9 BioVision
7.9.1 BioVision Idelalisib (CAL-101) Corporation Information
7.9.2 BioVision Idelalisib (CAL-101) Product Portfolio
7.9.3 BioVision Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.9.4 BioVision Main Business and Markets Served
7.9.5 BioVision Recent Developments/Updates
7.10 Santa Cruz Biotechnology
7.10.1 Santa Cruz Biotechnology Idelalisib (CAL-101) Corporation Information
7.10.2 Santa Cruz Biotechnology Idelalisib (CAL-101) Product Portfolio
7.10.3 Santa Cruz Biotechnology Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Santa Cruz Biotechnology Main Business and Markets Served
7.10.5 Santa Cruz Biotechnology Recent Developments/Updates
7.11 Clearsynth
7.11.1 Clearsynth Idelalisib (CAL-101) Corporation Information
7.11.2 Clearsynth Idelalisib (CAL-101) Product Portfolio
7.11.3 Clearsynth Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Clearsynth Main Business and Markets Served
7.11.5 Clearsynth Recent Developments/Updates
7.12 LGC
7.12.1 LGC Idelalisib (CAL-101) Corporation Information
7.12.2 LGC Idelalisib (CAL-101) Product Portfolio
7.12.3 LGC Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.12.4 LGC Main Business and Markets Served
7.12.5 LGC Recent Developments/Updates
7.13 LKT Laboratories
7.13.1 LKT Laboratories Idelalisib (CAL-101) Corporation Information
7.13.2 LKT Laboratories Idelalisib (CAL-101) Product Portfolio
7.13.3 LKT Laboratories Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.13.4 LKT Laboratories Main Business and Markets Served
7.13.5 LKT Laboratories Recent Developments/Updates
7.14 Shimadzu
7.14.1 Shimadzu Idelalisib (CAL-101) Corporation Information
7.14.2 Shimadzu Idelalisib (CAL-101) Product Portfolio
7.14.3 Shimadzu Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Shimadzu Main Business and Markets Served
7.14.5 Shimadzu Recent Developments/Updates
7.15 Aladdin
7.15.1 Aladdin Idelalisib (CAL-101) Corporation Information
7.15.2 Aladdin Idelalisib (CAL-101) Product Portfolio
7.15.3 Aladdin Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Aladdin Main Business and Markets Served
7.15.5 Aladdin Recent Developments/Updates
7.16 Cayman Chemical
7.16.1 Cayman Chemical Idelalisib (CAL-101) Corporation Information
7.16.2 Cayman Chemical Idelalisib (CAL-101) Product Portfolio
7.16.3 Cayman Chemical Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Cayman Chemical Main Business and Markets Served
7.16.5 Cayman Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Idelalisib (CAL-101) Industry Chain Analysis
8.2 Idelalisib (CAL-101) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Idelalisib (CAL-101) Production Mode & Process
8.4 Idelalisib (CAL-101) Sales and Marketing
8.4.1 Idelalisib (CAL-101) Sales Channels
8.4.2 Idelalisib (CAL-101) Distributors
8.5 Idelalisib (CAL-101) Customers
9 Idelalisib (CAL-101) Market Dynamics
9.1 Idelalisib (CAL-101) Industry Trends
9.2 Idelalisib (CAL-101) Market Drivers
9.3 Idelalisib (CAL-101) Market Challenges
9.4 Idelalisib (CAL-101) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TCI
Biosynth Carbosynth
BOC Sciences
Focus Biomolecules
Adooq Bioscience
Selleck Chemicals
Enzo Biochem
Axon Medchem
BioVision
Santa Cruz Biotechnology
Clearsynth
LGC
LKT Laboratories
Shimadzu
Aladdin
Cayman Chemical
听
听
*If Applicable.
